UK Innovation & Science Seed Fund News

Medical technology company Presymptom Health has successfully closed its seed round funding to support the development of its pioneering blood test for the early detection of sepsis. Presymptom Health’s diagnostic test builds on work originally researched over 10 years at the Defence Science and Technology Laboratory (Dstl). Initial trials in patients show it can predict […]

read more

London, UK, 19th July 2021 / The UK Innovation and Science Seed Fund (UKI2S) is pleased to announce the appointment of Dr Andrew Mackintosh as the new Chair of its Advisory Board. UKI2S enables and accelerates the commercial success of innovative companies from the UK’s publicly funded research base ranging from nuclear fusion to agrifoods and from synthetic […]

read more

Coventry, UK, 19th July 2021 / NanoSyrinx, a biotech company developing a new cell engineering tool for novel targeted therapeutic modalities, has raised a further £6.2m of seed financing, co-led by incoming Octopus Ventures and existing investor M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck. Previous investors BioCity (now We are Pioneer […]

read more

1 2 3 40